Xiao Yin Selected Research

Circulating Neoplastic Cells

1/2020

A Multifunctional Platform for the Capture, Release, And Enumeration of Circulating Tumor Cells Based on Aptamer Binding, Nicking Endonuclease-Assisted Amplification, And Inductively Coupled Plasma Mass Spectrometry Detection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiao Yin Research Topics

Disease

5	Neoplasms (Cancer) 06/2022 - 10/2017
4	Obesity 01/2022 - 09/2012
4	Infections 01/2022 - 01/2010
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022 - 09/2012
3	Overweight 01/2020 - 09/2012
2	Necrosis 01/2021 - 08/2009
2	Type 2 Diabetes Mellitus (MODY) 01/2021 - 05/2013
2	Vitamin D Deficiency 01/2016 - 09/2012
2	Human Influenza (Influenza) 09/2012 - 05/2010
2	Influenza in Birds (Avian Flu) 11/2011 - 05/2010
1	Postoperative Pain 06/2022
1	Hemangioma (Angioma) 11/2021
1	Proteinuria 07/2021
1	Poisoning 07/2021
1	Malaria 01/2021
1	Diabetes Complications 01/2021
1	Hypertension (High Blood Pressure) 01/2020
1	Circulating Neoplastic Cells 01/2020
1	Hypothyroidism 12/2018
1	Chronic Disease (Chronic Diseases) 11/2018
1	Dementia (Dementias) 11/2018
1	Cognitive Dysfunction 11/2018
1	Sensorineural Hearing Loss 01/2017
1	Liver Diseases (Liver Disease) 01/2017
1	Inflammation (Inflammations) 08/2015
1	Glucose Intolerance 05/2013
1	Insulin Resistance 05/2013
1	Vaccinia 11/2011
1	Sepsis (Septicemia) 04/2011
1	Acute Lung Injury 04/2011
1	Carcinoma (Carcinomatosis) 04/2010
1	Laryngeal Neoplasms (Laryngeal Cancer) 04/2010
1	Hepatitis B 01/2010

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 01/2022 - 04/2011
4	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 05/2010
4	VaccinesIBA 10/2015 - 01/2010
2	Biomarkers (Surrogate Marker)IBA 06/2022 - 11/2019
2	Blood Glucose (Blood Sugar)IBA 01/2021 - 01/2020
2	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 05/2013
2	Fluorescent Dyes (Fluorescent Probes)IBA 01/2018 - 10/2017
2	Vitamin D FDA LinkGeneric 01/2016 - 09/2012
2	AntigensIBA 11/2011 - 05/2010
1	Opioid Analgesics (Opioids)IBA 06/2022
1	IntegrinsIBA 01/2022
1	Cyclophilin AIBA 01/2022
1	Polidocanol (Laureth)FDA Link 11/2021
1	Indicators and Reagents (Reagents)IBA 07/2021
1	MicroRNAs (MicroRNA)IBA 07/2021
1	Nucleic AcidsIBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	MyokinesIBA 01/2020
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2020
1	EndonucleasesIBA 01/2020
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2020
1	Uncoupling Protein 1IBA 01/2020
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2020
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2019
1	apolipoprotein B receptorIBA 12/2018
1	Fatty Acid Synthases (Fatty Acid Synthase)IBA 12/2018
1	GoldIBA 01/2018
1	Messenger RNA (mRNA)IBA 01/2018
1	Epithelial Cell Adhesion MoleculeIBA 10/2017
1	Biological ProductsIBA 10/2017
1	Immunoglobulin G (IgG)IBA 10/2017
1	SteroidsIBA 01/2017
1	ethylene dichloride (1,2-dichloroethane)IBA 01/2017
1	TabletsIBA 01/2016
1	InflammasomesIBA 08/2015
1	Insulin (Novolin)FDA Link 05/2013
1	hydroxide ionIBA 09/2012
1	LuciferasesIBA 09/2012
1	DNA-Directed RNA Polymerases (RNA Polymerase)IBA 09/2012
1	Pharmaceutical PreparationsIBA 09/2012
1	N-nitrosallyl-2-oxopropylamine (NAOP)IBA 11/2011
1	CPG-oligonucleotideIBA 01/2010
1	QuartzIBA 08/2009

Therapy/Procedure

1	Anterior Cruciate Ligament Reconstruction 06/2022
1	Endoscopes 11/2021
1	Sclerotherapy 11/2021
1	Glycemic Control 01/2021
1	Activities of Daily Living (ADL) 11/2018
1	Secondary Prevention 11/2018
1	Precision Medicine 10/2017
1	Therapeutics 01/2017
1	Laryngectomy 04/2010